Skip to main content
Medical information Clinical review pending

Genetic Testing

Preimplantation Genetic Screening PGS Test

Preimplantation Genetic Screening (PGS) helps identify genetic abnormalities in embryos during IVF, increasing the chances of a healthy pregnancy. Available across Kenya.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Biopsied embryo cells. Specific collection and transport requirements apply.
Results
Results are typically available by the following Tuesday after sample receipt. Confirm with the laboratory before booking.
Preparation
Requires coordination with your IVF clinic. Ensure the Preimplantation Genetic Screening Consent form (Form 23) is completed prior to sample collection. Schedule sample collection and dispatch in advance.
Test priceKSh 32,760

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Preimplantation Genetic Screening PGS Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Couples undergoing IVF with recurrent implantation failure.
  • ✓Individuals with a family history of chromosomal abnormalities.
  • ✓Women of advanced maternal age (typically 35 years or older).
  • ✓Couples with a history of previous pregnancies affected by chromosomal abnormalities.
  • ✓Individuals seeking to reduce the risk of transmitting genetic disorders.
02

In plain language

What this test helps you understand

PGS helps identify embryos with chromosomal abnormalities, potentially increasing IVF success rates and reducing the risk of miscarriage or birth defects associated with aneuploidy.
The Preimplantation Genetic Screening (PGS) Test is a procedure used alongside in vitro fertilization (IVF) to screen embryos for genetic abnormalities before implantation. This test is designed to help couples facing infertility or those with a history of genetic disorders improve their chances of a successful pregnancy. It analyzes the genetic material of embryos to detect chromosomal issues like aneuploidy, which can lead to implantation failure, miscarriage, or genetic conditions in a child. Selecting genetically normal embryos for implantation can significantly increase the likelihood of a healthy pregnancy and reduce the risk of miscarriage. This test provides valuable information for informed decision-making during the IVF process.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationRequires coordination with your IVF clinic. Ensure the Preimplantation Genetic Screening Consent form (Form 23) is completed prior to sample collection. Schedule sample collection and dispatch in advance.
SampleBiopsied embryo cells. Specific collection and transport requirements apply.
MethodologyChromosomal analysis of biopsied embryo cells using techniques like Next-Generation Sequencing (NGS) or Comparative Genomic Hybridization (CGH). Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
PGS screens for common chromosomal abnormalities but may not detect all genetic conditions. It does not guarantee a successful pregnancy or the absence of all genetic issues. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

PGS is a test performed on embryos created through IVF to check for chromosomal abnormalities before they are implanted in the uterus.
PGS is often recommended for individuals undergoing IVF, especially those with advanced maternal age, a history of miscarriages, or known genetic concerns.
The test primarily looks for an abnormal number of chromosomes (aneuploidy) in the embryo cells.
The sample consists of a few cells biopsied from the embryo by the IVF laboratory. Specific instructions for submission are provided.
Results are typically available by the following Tuesday after the sample is received by the laboratory. Confirm with the laboratory before booking.
While PGS increases the chances of selecting a genetically normal embryo, it does not guarantee a successful pregnancy or the absence of all genetic conditions. Confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp